A detailed history of Davidson Investment Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Davidson Investment Advisors holds 282 shares of LLY stock, worth $288,119. This represents 0.01% of its overall portfolio holdings.

Number of Shares
282
Previous 282 -0.0%
Holding current value
$288,119
Previous $219,000 1.83%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025

BUY
$713.71 - $898.95 $201,266 - $253,503
282 New
282 $219,000
Q3 2017

Nov 09, 2017

SELL
$77.07 - $85.54 $7,706 - $8,554
-100 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
100
100 $8,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Davidson Investment Advisors Portfolio

Follow Davidson Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Davidson Investment Advisors with notifications on news.